Semin Musculoskelet Radiol 2019; 23(01): 076-084
DOI: 10.1055/s-0038-1676290
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Nerve Tumors: What the MSK Radiologist Should Know

Alberto Stefano Tagliafico
1   Department of Health Sciences (DISSAL), University of Genoa, Genova, Italy
2   IRCCS Ospedale Policlinico San Martino, Genova, Italy
,
Amanda Isaac
3   Guy's and St Thomas' Hospitals NHS Foundation Trust, London, United Kingdom
4   King's College London, London, United Kingdom
,
Bianca Bignotti
1   Department of Health Sciences (DISSAL), University of Genoa, Genova, Italy
,
Federica Rossi
1   Department of Health Sciences (DISSAL), University of Genoa, Genova, Italy
,
Federico Zaottini
1   Department of Health Sciences (DISSAL), University of Genoa, Genova, Italy
,
Carlo Martinoli
1   Department of Health Sciences (DISSAL), University of Genoa, Genova, Italy
2   IRCCS Ospedale Policlinico San Martino, Genova, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
30. Januar 2019 (online)

Abstract

Nerve tumors are rare and heterogeneous soft tissue tumors arising from a peripheral nerve or showing nerve sheath differentiation. In a radiologic setting it is necessary to recognize soft tissue lesions that are of neural origin, their association with a peripheral nerve, and whether they are a true tumor or a so-called pseudotumor such as a neuroma, fibrolipoma, or peripheral nerve sheath ganglion. Ultrasound (US) and magnetic resonance imaging are the best modalities to characterize these lesions. US can be used to guide biopsy in difficult and uncertain cases when the lesion is either indeterminate or possibly malignant. At present, no single imaging feature or reproducible criteria, or a combination, can differentiate reliably between a neurofibroma and a schwannoma or discriminate with certainty between benign and malignant neurogenic tumors. Adequate imaging and consultation with a nerve tumors/sarcoma unit is advised.

 
  • References

  • 1 Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Lyon, France: IARC Press; 2013
  • 2 National Cancer Institute. SEER Stat Fact Sheets: Soft tissue including heart cancer. Available at: http://seer.cancer.gov/statfacts// . Accessed July 8, 2018
  • 3 Kerezoudis P, Bydon M, Spinner RJ. Peripheral nerve sheath tumors: the “orphan disease” of national databases. World Neurosurg 2017; 103: 948-949
  • 4 Noebauer-Huhmann IM, Weber MA, Lalam RK. , et al. Soft tissue tumors in adults: ESSR-approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol 2015; 19 (05) e1
  • 5 Bignotti B, Zaottini F, Airaldi S, Martinoli C, Tagliafico A. Extraneural findings during peripheral nerve ultrasound: prevalence and further assessment. Muscle Nerve 2018; 57 (01) 65-69
  • 6 Warbey VS, Ferner RE, Dunn JT, Calonje E, O'Doherty MJ. [18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 2009; 36 (05) 751-757
  • 7 Afshar A, Assadzadeh O, Mohammadi A. Ultrasonographic diagnosis of lipofibromatous hamartoma of the median nerve. Iran J Radiol 2015; 12 (01) e11270
  • 8 Johnson RJ, Bonfiglio M. Lipofibromatous hamartoma of the median nerve. J Bone Joint Surg Am 1969; 51 (05) 984-990
  • 9 Shekhani HN, Hanna T, Johnson JO. Lipofibromatous hamartoma of the median nerve: a case report. J Radiol Case Rep 2016; 10 (11) 1-7
  • 10 Rusu GM, Ciuce C, Fodor L, Manole S, Dudea SM. Ultrasonographic and imaging appearance of peripheral intraneural vascular anomalies: report of two cases and review of the literature. Med Ultrason 2018; 20 (02) 237-246
  • 11 Prasad NK, Chawla A, Lalezari S. , et al. A radiological classification system for intraneural vascular anomalies: assessment of potential for resection with high-resolution MRI. Acta Neurochir (Wien) 2016; 158 (02) 329-334 ; discussion 334
  • 12 Abreu E, Aubert S, Wavreille G, Gheno R, Canella C, Cotten A. Peripheral tumor and tumor-like neurogenic lesions. Eur J Radiol 2013; 82 (01) 38-50
  • 13 Bignotti B, Signori A, Sormani MP, Molfetta L, Martinoli C, Tagliafico A. Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis. Eur Radiol 2015; 25 (08) 2254-2262
  • 14 Zanetti M, Ledermann T, Zollinger H, Hodler J. Efficacy of MR imaging in patients suspected of having Morton's neuroma. AJR Am J Roentgenol 1997; 168 (02) 529-532
  • 15 Tagliafico A, Altafini L, Garello I, Marchetti A, Gennaro S, Martinoli C. Traumatic neuropathies: spectrum of imaging findings and postoperative assessment. Semin Musculoskelet Radiol 2010; 14 (05) 512-522
  • 16 Murphey MD, Smith WS, Smith SE, Kransdorf MJ, Temple HT. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 1999; 19 (05) 1253-1280
  • 17 Soldatos T, Fisher S, Karri S, Ramzi A, Sharma R, Chhabra A. Advanced MR imaging of peripheral nerve sheath tumors including diffusion imaging. Semin Musculoskelet Radiol 2015; 19 (02) 179-190
  • 18 Ferner RE, Huson SM, Thomas N. , et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007; 44 (02) 81-88